FIELD: medicine.
SUBSTANCE: invention refers to production of an agent for lowering cyclophosphamide toxicity representing Agrimoniin.
EFFECT: agent does not exhibit a toxic effect, reduces general toxic action of cyclophosphamide, improves a survival value of joint treatment as compared with cyclophosphamide monotherapy in 10 times.
1 ex, 1 tbl, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREPARING POLYPHENOL AGENT FROM LADY'S MANTLE, CAPABLE OF REDUCING TOXICITY OF CYCLOPHOSPHAMIDE AND HAVING CYTOTOXIC ACTIVITY | 2010 |
|
RU2425690C1 |
METHOD OF OBTAINING MEDICATION FROM HERB OF LADY'S MANTLE, WHICH REDUCES CYCLOPHOSPHAMIDE TOXICITY | 2009 |
|
RU2403055C1 |
MEDIUM WITH ANTI-TUMOUR EFFECT AND METHOD OF ITS OBTAINMENT | 2007 |
|
RU2349317C1 |
METHOD OF LUNG CANCER TREATMENT | 2008 |
|
RU2365370C1 |
LUNG CANCER THERAPY | 2008 |
|
RU2367436C1 |
MEDICATION INCREASING ANTITUMOUR EFFECT OF METHOTREXATE | 2009 |
|
RU2411947C1 |
METHOD OF TREATING MALIGNANT PLEURISY | 2010 |
|
RU2438667C1 |
TETRAETHYL-2-(2,2,6,6-TETRAMETHYLPIPERIDIN-4-YLAMINO)-ETHYLENE-1,1-BISPHOSPHONATE POSSESSING ANTICANCER ACTIVITY | 2013 |
|
RU2506085C1 |
PHOSPHOLIPID COMPOSITION OF DOXORUBICIN FOR TREATING PATIENTS WITH BREAST CANCER | 2019 |
|
RU2714137C1 |
ANTITUMOR AGENT | 1998 |
|
RU2128042C1 |
Authors
Dates
2011-09-27—Published
2010-04-14—Filed